Medical students’ understanding of inhalation therapy & inhalers Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals Year: 2013
Delivery of medication by breath-actuated nebulizer (BAN) is similar when used with differing inhalation / exhalation ratios: A contrast to breath enhanced nebulizer (BEN) behavior Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014
Medical aerosols delivery hospitals and home, what is new? Source: Annual Congress 2007 - Primary care: delivering the goods: "inhaled therapies" Year: 2007
Effect of interval between actuations of albuterol HFA inhalers on their aerosol characteristics Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques Year: 2016
Inhaled medication delivery to infants via valved holding chamber with facemask: Not all VHCs perform the same Source: International Congress 2014 – Paediatric asthma: lung function testing and more Year: 2014
Reducing plastic waste, carbon footprint and cost: inhaler recycling at Musgrove Park Hospital Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018
Moleculer characterization of severe allergic asthma patients via exhaled breath volatile organic compounds(Ege University Translational Pulmonology Research Group [EgeTPRG]) Source: International Congress 2017 – Monitoring asthma control Year: 2017
The effect of inhalation duration on lung deposition with a pressurized metered-dose inhaler (pMDI) Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014
What the pulmonary specialist should know about the new inhalation therapies Source: Eur Respir J 2011; 37: 1308-1417 Year: 2011
Inhaled therapies: plastics, propellants, and pollutants Source: Virtual Congress 2021 – Environment, air pollution, health and respiratory disease Year: 2021
Domiciliary nebuliser treatment: Do we follow the guidelines? Source: Eur Respir J 2003; 22: Suppl. 45, 147s Year: 2003
Sealed-lips instruction for pressurised metered dose inhalers (pMDIs) – A critical step? Source: International Congress 2014 – Management of asthma and other respiratory diseases in primary care Year: 2014
Effect of antistatic AeroChamber Plus® Flow-Vu® spacer on the systemic bioavailability of CHF5993 a novel triple pMDI Source: International Congress 2016 – Pulmonary drug delivery Year: 2016
Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Source: Annual Congress 2007 - ISAM - Expanding role of aerosols: systemic drug delivery, gene therapy and vaccination Year: 2007
Occupational asthma from cleaning agents: shield revisited Source: Annual Congress 2008 - Occupational asthma - agents and management Year: 2008
In vitro lung deposition of fluticasone propionate/formoterol (FP/FORM) pressurized metered dose inhaler (pMDI) with different inhalation profiles Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014
Are extra-fine particles from dry powder inhalers likely to improve lung deposition? Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014
Valved holding chambers (VHCs) can have different medication delivery performance as a function of delay interval following actuation of the pressurized metered dose inhaler (pMDI) Source: International Congress 2014 – Respiratory symptoms in primary care populations Year: 2014
Single dose pharmacokinetics of C16TR for Inhalation (INS1009) vs treprostinil inhalation solution Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016